Fluoroquinolone Toxicity Study, formerly known as The Foundation for Fluoroquinolones Toxicity Study and Research, was recognized exclusively as a charitable 501(c)(3) nonprofit organization under Federal Tax Exemption and Illinois Sales and Use Tax Exemption on October 07, 2015. We know there are many websites about Fluoroquinolone toxicity awareness, therefore, this website is mainly intended for the medical and science communities.
The Foundation was the first known to have organized both a human in vivo and in vitro study for Fluoroquinolone genomic and mitochondrial DNA adducts. Our organization sent our 2017 research study results to scientists and governments around the world as well as to the FDA, EPA, EMA, WHO, US Health Department, global Ministries of Health, members of Congress, Senate and the White House. Cooperation between the European Medicines Agency (EMA) and the Pharmacovigilance Risk Assessment Committee (PRAC), contributed to the message about the possibility of mitochondrial damage being conveyed to European citizens, the medical community and referenced in the PRAC 2018 report.
Please dedicate a few minutes to watch our foundation video: https://youtu.be/t_zBhMi5AYs
This website is dedicated to the late Dr. Jay Cohen, a pioneer of Fluoroquinolone drug warning, and the countless victims who have suffered long-term and permanent damage from Fluoroquinolone toxicity, losing health, finances, jobs, relationships, and life as they knew it. To the courageous ones we call warriors, who risk everything to give those victims a voice, we say thank you immensely. If you would like to make a donation towards continued research, it is greatly appreciated. We would like to thank everyone who made even the smallest donation.
If you would like to collaborate with us, please go to our contact page.
The Foundation was created to explore a path to recovery for the masses of drug damaged victims around the world. By funding our own research studies and conveying those findings to the medical and science communities, we hope to create change in how these drugs are used.
Our mission is to perform research at the cellular and molecular level in collaboration with scientists to determine the mechanism of damage caused by Fluoroquinolones. With these study conclusions, evaluation of preventative and restorative treatment will be explored.
In Jerzy's early years, he studied High Tech Electronics in Rzeszów, Poland and graduated in 1984. He enrolled in the NCO air force school in Grudziadz supervising flight safety, graduating two years later. With previous medical education from 1998-2000, he attended the Marco Polo School in Chicago to become state licensed in bodywork. He went on to expand his education to sport and medical therapy and more. In the early 2000's, he created distribution channels in the U.S. and EU for medical and cosmetic devices. In the last 25 years, Jerzy and his wife purchased dental and medical buildings which he managed while still practicing his work on patients. In 2015, after multiple episodes of Fluoroquinolone damage resulting in a cascade of severe health, he was forced to quit his job and sell many of his clinics. Jerzy started independent research on Fluoroquinolone toxicity and established the non-profit, Fluoroquinolone Toxicity Study, with Jane Crosby. Engaging with scientists at home and abroad, they analyzed thousands of science publications on quinolones. Seeing the dire need for research, the Foundation organized the first known individual in vitro tests for genomic and mitochondrial Fluoroquinolone DNA adducts and in vivo study of over 50 Fluoroquinolone damaged and disabled participants. Jerzy believes our continued studies may provide a treatment and that more doctors will understand the toxicity danger. Our current 2020 study will hopefully allow us to travel this course.
Damaged by Levaquin in 2009, Jane became a member of the Fluoroquinilone Toxicity Group in Facebook and in 2013 joined the team of administrators in several online support groups for Fluoroquinolone victims. She has dedicated the last seven years continuing to help administrate these groups, faithfully remaining in touch with the communities’ needs. She developed a friendship with Dr. Jay Cohen, author of the book How We Can Halt the Cipro and Levaquin Catastrophe; The Worst Medication Disaster in U.S. History. Dr. Cohen published his book in time for a public hearing between the FDA and a group of severely damaged Fluoroquinolone victims and commissioned Jane to deliver a signed copy to the head of a FDA advisory panel. In 2015 she co-founded Fluoroquinolone Toxicity Study with Jerzy Tyszkowski. In addition to arranging study parameters and participant selection for the Foundation's studies, Jane’s hope is to find effective treatments for patient recovery and advocate for justice on behalf of those whose livelihoods and health have been lost due to the adverse events of Fluoroquinolone toxicity.
Sarah graduated from the University of MN in 1989. She found herself facing a significant setback in 2013 when she was affected by Fluoroquinolones for the third time in her life. The severity of the condition compelled her to permanently withdraw from the workforce, redirecting her focus towards her health and disabilities. Her motivation to join the Foundation stemmed from her desire to channel her energy towards a purposeful endeavor that could generate positive outcomes. With a professional background in tech start-up operations and commercial property portfolio management, Sarah brings valuable organizational and operational skills to the Foundation. She assumes responsibility for managing the website, online media, and written communications with victims, various entities, and government departments on both national and international levels. Over the past decade, Sarah played a pivotal role in leading local teams to achieve successful outcomes in California state propositions. Now, she channels her unwavering dedication and determination towards contributing to the Foundation's ongoing journey.
Dr. Gustavson graduated with a Doctor of Medicine from the University of Texas Medical Branch, Galveston, in 1992. After a past immersed in various biological research projects and responsibility for several federal grant projects, he commenced his residency in Psychiatry at Good Samaritan Regional Medical Center and then general neurology with subspecialty and research fellowship at the UCLA School of Medicine. He is the recipient of numerous academic awards, including the John Douglas French Alzheimer’s Foundation Research Fellowship Award and named Diana Streisand Kind Fellow in August, 2003. With numerous publications on his research in scientific and academic journals, Dr. Gustavson has also extensively lectured to academic, clinical and educational institutions spanning the last 30 years. Currently, he is in private practice as a Behavioral Neurologist. Experiencing the toxic effects of Fluoroquinolones himself, Dr. Gustavson joined the Foundation to advise on clinical and scientific projects identifying effects and mechanism of injury related to this class of antibiotics.
As a graduate from UAMS College of Medicine in 2009, Dr. Beard did her residency in Family Medicine and chose to work in the ER treating patients for urgent and emergent conditions. She started her own primary care concierge practice in 2013 which morphed into a functional medicine practice treating diverse cases. In 2016 she also took on the position as Medical Director of Cardiac Rehab at the Arkansas Heart Hospital and obtained her Functional Medicine Certification in 2017. Dr. Beard continues to practice functional medicine at her clinic, helping patients to unlock their health potential. Due to the lack of Fluoroquinolone awareness, her hope is to see more shared education between the floxed and medical communities and a reduction of misinformation about these and other drugs that have the potential to cause significant harm.
In 2019, Marco experienced a severe reaction to multiple courses of ciprofloxacin in the midst of his medical studies at the University of Zurich, Switzerland. This ordeal forced him to make significant adjustments to both his personal and professional life. After recovering to a degree, he approached his university education with newfound determination – his purpose now was to educate as many healthcare professionals as possible about the dangers of fluoroquinolone toxicity.
Currently in his final year of medical school,
Marco is simultaneously working on a publication about fluoroquinolone-induced small fiber neuropathy and collaborating on this ongoing research with Dr. Stefan Pieper, the author of "Fluoroquinolone-Associated Disability (FQAD): Pathogenesis, Diagnostics, Therapy, and Diagnostic Criteria." Additionally, Marco is an active member of FQAD Support, an organization dedicated to providing assistance to individuals experiencing systemic adverse effects from fluoroquinolone antibiotics.
Your support will help fund current and future research studies